HHS cancels data collection deadline scheduled for today to inform remdesivir distribution

May 18, 2020 - 02:53 PM
hhs-health-and-human-services-seal

The Department of Health and Human Services has canceled today’s deadline for hospitals and health systems to submit data to inform the agency’s distribution of its supply of remdesivir. The deadline for submitting data into HHS’s TeleTracking system was supposed to be at 11:59 p.m. ET today.

Late last week, HHS notified hospitals that another round of data were to be collected by midnight tonight to inform the distribution of the remdesivir that Gilead donated to the U.S. Over the weekend, HHS determined that it did not need the additional data at this time. Registered users of the TeleTracking portal received an email announcing the agency’s decision to postpone data collection.

While hospitals do not have to submit the COVID-19 admission and COVID-19 intensive care unit occupancy data to TeleTracking today, HHS has indicated it intends to ask for updated data again in the next few weeks.

The AHA has urged HHS to share a data reporting schedule with hospitals so that their teams know well in advance when the data are due and plan to fulfill the request. 

Related News Articles

Headline
HHS awards $600M to make COVID-19 tests; public can order 4 more free
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response yesterday awarded $600 million for 12 domestic COVID-19…
Headline
AHA participates in CDC Fall Immunization Kick-off; COVID-19 vaccines for uninsured still free
AHA today participated in a Centers for Disease Control and Prevention Fall Immunization Kick-off Event for partner organizations, which focused on vaccinating…
Headline
The ABCs of COVID-19 vaccines highlight new AHA social media toolkit
AHA is providing its latest social media toolkit to help hospitals encourage vaccination against COVID-19. The newest toolkit includes messages and assets…
Headline
FDA advisor declares ineffectiveness of widely used over-the-counter decongestant active ingredient
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…
Headline
CDC recommends updated Moderna, Pfizer COVID-19 vaccines
As authorized yesterday by the Food and Drug Administration and recommended by its vaccine advisory committee, the Centers for Disease Control and Prevention…
Headline
HHS highlights price cap in contract to develop COVID-19 monoclonal antibody
Under the Department of Health and Human Services’ recent agreement with Regeneron to develop a new monoclonal antibody to prevent COVID-19, the U.S. list…